Shifting the Paradigm in the Management of Hemophilia A: Transitioning to a Young Adult Wednesday, June 3, 2020 - Thursday, June 3, 2021     CME Provider: Excel Continuing Education › Grace Rebull 7990 SW 64th Street Miami, Florida (FL) 33143 United States   Phone: 305-630-9414   Visit the CME Provider Webpage ›   Description: 3-part series, each for .50 credits. Hemophilia, primarily diagnosed in infancy and early childhood, is a genetic disorder characterized by spontaneous or excessive bleeding predominantly into the weight-bearing joints or muscles. Most individuals are impacted through adolescence, adulthood, and into old age. This CME-accredited activity will review recent breakthroughs addressing the limitations of regular, prophylactic infusion of missing coagulation factors VIII/IX, discuss current and emerging therapies and treatment regimens, highlight risks and prevention of progressive degenerative joint changes, and explore practical implications of novel developments, while addressing “transition strategies” for adolescent care in the changing landscape of hemophilia.   View the Course Brochure ›     Instructors: Joanna A. Davis, MD Medical Director Pediatric Comprehensive Hemophilia Treatment Center Associate Professor University of Miami Miller School of Medicine - Miami, FL Jonathan Roberts, MD Associate Medical Director Bleeding & Clotting Disorders Institute Assistant Professor of Pediatrics University of Illinois College of Medicine - Peoria, IL Shannon Meeks, MD Program Medical Director of Hemostasis/ Thrombosis Aflac Cancer and Blood Disorders Center Children’s Healthcare of Atlanta Associate Professor of Pediatrics Emory University School of Medicine - Atlanta, GA     CME Credit: Physicians:  1.5 Hours Physician Assistants:  1.5 Hours Nurses:  1.5 Hours Self Assessment Module (SAM):  Yes Specialty Audience: Family Medicine    Internal Medicine    Pediatrics     RADLIST Course #23302